Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 0.36% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.36% | |
| Gapped Up | Strength | 0.36% | |
| 20 DMA Resistance | Bearish | 0.19% | |
| Gapped Up | Strength | 0.19% | |
| NR7 | Range Contraction | 3.16% |
| Alert | Time |
|---|---|
| Reversed from Up | about 14 hours ago |
| Possible Inside Day | about 14 hours ago |
| 20 DMA Support | about 15 hours ago |
| Gap Up Closed | about 15 hours ago |
| 20 DMA Resistance | about 15 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 302.68 |
| 52 Week Low | 119.7604 |
| Average Volume | 535,586 |
| 200-Day Moving Average | 201.58 |
| 50-Day Moving Average | 235.62 |
| 20-Day Moving Average | 211.39 |
| 10-Day Moving Average | 215.37 |
| Average True Range | 12.25 |
| RSI (14) | 45.05 |
| ADX | 16.43 |
| +DI | 22.88 |
| -DI | 25.46 |
| Chandelier Exit (Long, 3 ATRs) | 199.89 |
| Chandelier Exit (Short, 3 ATRs) | 225.76 |
| Upper Bollinger Bands | 231.66 |
| Lower Bollinger Band | 191.13 |
| Percent B (%b) | 0.51 |
| BandWidth | 19.17 |
| MACD Line | -5.91 |
| MACD Signal Line | -6.92 |
| MACD Histogram | 1.0103 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 226.08 | ||||
| Resistance 3 (R3) | 227.11 | 223.36 | 223.69 | ||
| Resistance 2 (R2) | 223.36 | 219.71 | 222.85 | 222.89 | |
| Resistance 1 (R1) | 217.55 | 217.45 | 215.67 | 216.51 | 222.09 |
| Pivot Point | 213.80 | 213.80 | 212.86 | 213.28 | 213.80 |
| Support 1 (S1) | 207.98 | 210.14 | 206.11 | 206.95 | 201.37 |
| Support 2 (S2) | 204.23 | 207.89 | 203.72 | 200.57 | |
| Support 3 (S3) | 198.42 | 204.23 | 199.77 | ||
| Support 4 (S4) | 197.38 |
